拔管后立即使用高流量鼻导管氧疗与传统氧疗或无创通气的比较:系统评价与荟萃分析
该系统评价与荟萃分析纳入8项随机对照试验共1594例重症成人,比较拔管后高流量鼻导管氧疗与其他无创给氧方式。与传统氧疗相比,高流量鼻导管氧疗降低再插管(RR 0.46,95%CI 0.30-0.70)和拔管后呼吸衰竭(RR 0.52,95%CI 0.30-0.91),对死亡率(RR 0.93,95%CI 0.57-1.52)和ICU住院时间(平均差0.05天更少,95%CI 0.83天更少至0.73天更多)无影响。与无创通气相比,高流量鼻导管氧疗对再插管(RR 1.16,95%CI 0.86-1.57)、死亡率(RR 1.12,95%CI 0.82-1.53)或拔管后呼吸衰竭(RR 0.82,95%CI 0.48-1.41)无影响。高流量鼻导管氧疗可能减少无创通气使用(RR 0.64,95%CI 0.34-1.22)和住院时间(平均差0.98天更少,95%CI 2.16天更少至0.21天更多),但精确性受限。
要点
- 与传统氧疗相比,高流量鼻导管氧疗降低拔管后再插管风险(RR 0.46,95%CI 0.30-0.70,中等确定性)。
- 与传统氧疗相比,高流量鼻导管氧疗降低拔管后呼吸衰竭风险(RR 0.52,95%CI 0.30-0.91,极低确定性)。
- 与无创通气相比,高流量鼻导管氧疗对再插管无影响(RR 1.16,95%CI 0.86-1.57,低确定性)。
- 高流量鼻导管氧疗可能减少无创通气使用(RR 0.64,95%CI 0.34-1.22,中等确定性,精确性受限)和住院时间(平均差0.98天更少,95%CI 2.16天更少至0.21天更多,中等确定性,精确性受限)。
- 高流量鼻导管氧疗对死亡率无影响:与传统氧疗相比RR 0.93(95%CI 0.57-1.52),与无创通气相比RR 1.12(95%CI 0.82-1.53)。
适用人群与场景
- 重症成人拔管后立即需要无创氧疗的患者。
研究设计与关键结果
- 系统评价与荟萃分析纳入8项随机对照试验,共1594例患者。
- 与传统氧疗相比,高流量鼻导管氧疗降低再插管(RR 0.46,95%CI 0.30-0.70,中等确定性)和拔管后呼吸衰竭(RR 0.52,95%CI 0.30-0.91,极低确定性),对死亡率(RR 0.93,95%CI 0.57-1.52,中等确定性)和ICU住院时间(平均差0.05天更少,95%CI 0.83天更少至0.73天更多,高确定性)无影响。
- 与传统氧疗相比,高流量鼻导管氧疗可能减少无创通气使用(RR 0.64,95%CI 0.34-1.22,中等确定性,精确性受限)和住院时间(平均差0.98天更少,95%CI 2.16天更少至0.21天更多,中等确定性,精确性受限)。
- 与无创通气相比,高流量鼻导管氧疗对再插管(RR 1.16,95%CI 0.86-1.57,低确定性)、死亡率(RR 1.12,95%CI 0.82-1.53,中等确定性)或拔管后呼吸衰竭(RR 0.82,95%CI 0.48-1.41,极低确定性)无影响。
- 与无创通气相比,高流量鼻导管氧疗可能减少ICU住院时间(中等确定性)和住院时间(中等确定性)。
证据类型、等级与局限
- 证据类型:系统评价与荟萃分析,纳入8项随机对照试验。
- 主要结局证据确定性:再插管(与传统氧疗比较)中等确定性;拔管后呼吸衰竭(与传统氧疗比较)极低确定性;死亡率(与传统氧疗比较)中等确定性;ICU住院时间(与传统氧疗比较)高确定性。
- 与无创通气比较:再插管低确定性;死亡率中等确定性;拔管后呼吸衰竭极低确定性;ICU住院时间和住院时间中等确定性。
- 无创通气使用和住院时间(与传统氧疗比较)因精确性受限,确定性受限。
- 局限:原文未报告局限性。
对床旁实践的改变
- 重症成人拔管后,与传统氧疗相比,高流量鼻导管氧疗可降低再插管风险,支持其用于拔管后氧疗。
- 与无创通气相比,高流量鼻导管氧疗在再插管方面无差异,选择时需结合患者耐受性和其他临床因素。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Reintubation after failed extubation is associated with increased mortality and longer hospital length of stay. Noninvasive oxygenation modalities may prevent reintubation. We conducted a systematic review and meta-analysis to determine the safety and efficacy of high-flow nasal cannula after extubation in critically ill adults.
DATA SOURCES: We searched MEDLINE, EMBASE, and Web of Science.
STUDY SELECTION: We included randomized controlled trials comparing high-flow nasal cannula to other noninvasive methods of oxygen delivery after extubation in critically ill adults.
DATA EXTRACTION: We included the following outcomes: reintubation, postextubation respiratory failure, mortality, use of noninvasive ventilation, ICU and hospital length of stay, complications, and comfort.
DATA SYNTHESIS: We included eight randomized controlled trials (n = 1,594 patients). Compared with conventional oxygen therapy, high-flow nasal cannula decreased reintubation (relative risk, 0.46; 95% CI, 0.30-0.70; moderate certainty) and postextubation respiratory failure (relative risk, 0.52; 95% CI, 0.30-0.91; very low certainty), but had no effect on mortality (relative risk, 0.93; 95% CI, 0.57-1.52; moderate certainty), or ICU length of stay (mean difference, 0.05 d fewer; 95% CI, 0.83 d fewer to 0.73 d more; high certainty). High-flow nasal cannula may decrease use of noninvasive ventilation (relative risk, 0.64; 95% CI, 0.34-1.22; moderate certainty) and hospital length of stay (mean difference, 0.98 d fewer; 95% CI, 2.16 d fewer to 0.21 d more; moderate certainty) compared with conventional oxygen therapy, however, certainty was limited by imprecision. Compared with noninvasive ventilation, high-flow nasal cannula had no effect on reintubation (relative risk, 1.16; 95% CI, 0.86-1.57; low certainty), mortality (relative risk, 1.12; 95% CI, 0.82-1.53; moderate certainty), or postextubation respiratory failure (relative risk, 0.82; 95% CI, 0.48-1.41; very low certainty). High-flow nasal cannula may reduce ICU length of stay (moderate certainty) and hospital length of stay (moderate certainty) compared with noninvasive ventilation.
CONCLUSIONS: High-flow nasal cannula reduces reintubation compared with conventional oxygen therapy, but not compared with noninvasive ventilation after extubation.
参考来源
- Granton D, Chaudhuri D, Wang D, et al. High-Flow Nasal Cannula Compared With Conventional Oxygen Therapy or Noninvasive Ventilation Immediately Postextubation: A Systematic Review and Meta-Analysis. Crit Care Med. 2020. PMID: 32947472. doi:10.1097/CCM.0000000000004576
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。